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Phosphorylase kinase (Phk), a key regulatory enzyme in glycogenolysis, is a 
hexadecameric protein that contains four different subunits with a stoichiometry (αβδ)4.  
Alpha and β are regulatory subunits,  is catalytic and δ is an intrinsic molecule of 
calmodulin.  The gene that encodes for the subunit PHKG1 undergoes alternative 
processing to produce a truncated form of  containing 181 residues (181) instead of the 
normal 387 residues.  Although much of the kinase helical domain is absent, 181 is still 
catalytic with its activity being influenced by PKC, and its mRNA being expressed in 
high levels in brain. S peptide is the only known in vitro substrate for 181.  In the 
present study, we are using the LexA-based yeast two-hybrid system to identify binding 
partners for 181.  Gamma181 was cloned into the pLexA vector and used as bait to 
screen a human fetal brain cDNA library.  Interactions between 181 and cDNA library 
proteins were monitored by auxotropic growth of the yeast in the absence of leucine and 
by expression of -galactosidase activity.  Following screening for leucine prototrophy 
and -galactosidase activity, we obtained 37 colonies that show positive for leucine 
prototrophy, although only 20 of these colonies were -galactosidase positive. Among 
these 20 colonies, 7 unique clones were identified corresponding to the proteins RPL23, 
RPL9, and NA14.  The physiological relevance of these interactions in the brain is yet to 
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be discovered. 
 
 3 
 
Introduction 
 
A. Phosphorylase kinase 
Phosphorylase kinase (Phk), the first protein kinase discovered, belongs to the 
serine/threonine kinase super family. Phk, a key regulatory enzyme of glycogenolysis, is 
a hexadecameric protein that contains four different subunits with a stoichiometry of 
(αβγδ)4 and molecular mass of 1.3x10
6
 Da (Brushia and Walsh, 1999; Cohen, 1973).  
Alpha and β are regulatory subunits, γ is catalytic (Skuster et al., 1980) and δ is an 
intrinsic molecule of calmodulin which binds tightly to the holoenzyme (Cohen et al., 
1978; Grand et al., 1981). 
Phosphorylase kinase has a vast diversity of expression levels in different tissues 
with liver and muscle having higher amounts. Determination of the spatial expression 
pattern of the Phk subunits by Expressed Sequenced Tag (EST) and UniGene database 
analysis revealed that Phk may be expressed in 28-36 different tissues (Winchester et al., 
2007).  In muscle cells Phk exists in two different compartments.  The bulk of the 
enzyme is located in the cytoplasm and is associated with the glycogen particles (Meyer 
et al., 1970).  Studies on localization of phosphorylase kinase revealed that a fraction of 
the Phk is directly associated with the membranes of T-tubules and sarcoplasmic 
reticulum of muscle cells (Thieleczek et al., 1987 and Dombradi et al., 1984).  
Farnesylation of the  and  subunits of Phk provided additional evidence for association 
of Phk with the membrane in muscle cells (Heilmeyer et al., 1992). Even though all of 
the enzyme molecules get farnesylated, only a small amount of Phk appears to be 
associated with the membranes.    
4 
 
 
Structurally, Phk is a complex enzyme made up of 16 subunits. Three dimensional 
structural studies of the Phk by cryo-electron microscopy (Bryan et al., 2009), negative 
staining, and scanning transmission electron microscopy (Trempe et al., 1986) reported a 
bilobal form of the enzyme also know as the butterfly like view (Fig.1.1). Eighty percent 
of the total mass of the enzyme is composed of the and  subunits, thus and  are the 
major contributors to the overall 3-D structure of Phk. 
                              
Fig. 1.1. Schematic location of the four subunits in the 3-D Cryo-EM volume of 
phosphorylase kinase holoenzyme (Venien-Bryan et al., 2009). 
 
In the butterfly like structure, Phk has two lobes which are connected at the center 
of the lobe by two bridges. The  subunit of Phk is located at the wing tips of the 
butterfly orientation of the holoenzyme (Wilkinson D.A., 1994). Proteolytic degradation 
of the  subunit by trypsin disrupts the butterfly structure of the holoenzyme whereas 
proteolysis of  subunit has little effect on the structure of Phk. This supports the idea 
that  is required to maintain the integrity of the structure, and it forms the bridge 
between the two lobes (Trempe et al., 1986). Phk protein crosslinking results in the 
formation of dimers which further supports that each bridge in the holoenzyme was 
formed by the  dimer (Ayers et al., 1998).   
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The  as well as  subunits of Phk are well known for their regulatory roles in the 
holoenzyme. The  subunit has 1237 amino acids with a molecular mass of 138 KDa 
(Zander et al., 1988). There are two separate genes encoding the two isoforms of the  
subunit, and a single gene encoding the multiple isoforms of the  subunit. Additionally, 
two forms of the muscle specific  subunit exist as a result of alternative splicing of the 
PHKA1 gene; the truncated form lacks 59 amino acids in the middle of the polypeptide 
(Harmann et al., 1991). In the nonactivated holoenzyme, quaternary interactions of the  
and  subunits inhibit the catalytic activity of the  subunit (Paudel and Carlson, 1987).  
The presence of highly conserved glucoamylase like domains in the  and  subunits 
suggests a functional role for these subunits in release of glucose from the nonreducing 
ends of glycogen in addition to the regulation of the Phk holoenzyme (Pallen, 2003). 
Extrinsic calmodulin, also known as ’, also activates the Phk by directly binding to the  
and  subunits. This activation purely depends  on the presence of calcium. The ’ 
subunit will not activate the tryptic and chymotryptic digests of Phk which provides 
evidence for interaction of the ’ subunit with the ,  subunits (Picton et al., 1980). 
The  subunit maintains the structural integrity of the holoenzyme (Trempe et al., 
1986). The  subunit consists of 1029 amino acid residues and has two serine 
phosphorylation sites, -26 and -700 that are good substrates for protein kinase A 
(Heilmeyer, 1991).  Residues 420-436 of the  subunit contain a region that has sequence 
homology with the natural substrate glycogen phosphorylase b (Pb) which acts as an auto 
inhibitor and regulates the activity of the  subunit (Sanchez and Carlson, 1993).  
Phosphorylation and farnesylation are the two post translational modifications that occur 
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on the  and  subunits. The exact function of farnesylation of the  and subunits in 
vivo is unknown. A cluster of 7 phosphorylation sites (aka multiphosphorylation domain) 
was identified in the  subunit.  
The  subunit of phosphorylase kinase has a molecular mass of 41,000 daltons 
(Cohen, 1973) and harbors the catalytic site. The N-terminus of the  subunit (amino 
acids 1-298) shares extensive sequence homology with the catalytic domain of most 
kinases, whereas the C-terminal region (last 110 amino acids) shows sequence homology 
with the calmodulin dependent kinase troponin I. 
 
 
 
         
 
                               
 
Fig. 1.2. Schematic representation of the  subunit of phosphorylase kinase 
(Owen et al., 1995). 
 
The C-terminus of the  subunit mediates the interaction with the  and  subunits. The 
subunit has two noncontiguous calmodulin binding sites, 302-326 and 342-366. Both 
of these are rich in positively charged amino acids and bind to the subunit 
Kinase catalytic 
core 
Amino terminal portion 
Nucleotide 
binding 
Linker region 
C terminal regulatory 
domain 
Calmodulin binding region 
Putative pseudosubstrate 
Auto inhibitor 
region   
rereregionregion 
1           20                       276         302-327              342-367    386         
Kinase  catalytic 
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simultaneously (Dasgupta et al., 1989). Electrostatic interactions play an important role in 
the interaction between the  and  subunits because there is a drastic reduction in the 
activation of the  subunit by the  subunit when the acid residues in the E helices of the 
 subunit are changed to basic residues (Farrar et al., 1993).  The C-terminal region of the 
 subunit (residues 302-312) acts as an auto inhibitory region. In vitro studies with a 
peptide corresponding to amino acids 302-312 have shown that this peptide binds to the 
catalytic site of a truncated  subunit (1-300) and acts as an inhibitor. This peptide called 
Phk13-1, also decreases the ATPase activity of the truncated  (1-300) (Bartleson & 
Graves., 2001). Yeast two-hybrid and protein crosslinking studies by Rice et al., (2002) 
showed the C-terminus of the subunit (amino acids1060-1237) interacts with the C-
terminus of the  subunit (amino acids 343-386). Furthermore, there is an increase in  
heterodimer formation in the presence of Ca
2+
 which reveals that Ca
2+
indirectly mediates 
changes in the interaction between the  and  subunits (Rice et al., 2002).  Studies with a 
purified  subunit show high catalytic activity even in presence of EGTA, suggesting that 
Ca
2+ 
is not required for the purified  subunit of Phk to maintain its activity (Skuster et 
al., 1980).   The purified  subunit also phosphorylates well-known in vitro substrates of 
Phk such as myelin basic protein, k-casein, skeletal muscle troponin complex and 
troponin T.  Free Mg
2+
 activates the  subunit whereas free Mn
2+
 inhibits the activity 
(Kee and Graves, 1987). By using two different database searches Winchester et al., 
(2007) showed that the , , and  subunits undergo extensive posttranscriptional 
processing.  The PHKG1 gene which encodes the subunit of Phk, undergoes alternative 
cleavage and polyadenylation in intron 6 which results in the formation of a truncated 
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form of the  subunit resulting in 181 amino acids instead of the normal 387 amino acids. 
The transcriptional expression level of this truncated form of  is proposed to be high in 
the brain (Winchester et al., 2007).    
The  subunit of Phk consists of a single polypeptide of 148 amino acids with a 
molecular weight of 16,680 daltons (Grand et al., 1981). It is an intrinsic molecule of 
calmodulin that confers the Ca
2+
 sensitivity to Phk, and it associates tightly with the  
subunit even in the absence of Ca
2+ 
(Picton et al., 1980).  While unusual, this is not an 
exceptional case because it has been shown that adenylate cyclase from the bacterium B. 
pertusis has two calmodulin binding domains and associates with  calmodulin even in the 
absence of Ca
2+
, which helps to protect the adenylate cyclase from proteolytic 
degradation (Ladant, 1988). In addition to this, the  subunit also provides a stabilizing 
role in Phk and prevents the aggregation of the and  subunits in the holoenzyme 
thus confining the number of protomers of Phk (Paudel & Carlson, 1990). It also plays a 
dual role in the holoenzyme.  In the absence of calcium, it inhibits Phk activity, and in the 
presence of calcium it activates Phk (Hessova et al., 1985) suggesting a tight association 
of the  subunit with the enzyme even in the absence of calcium. Purified  subunit, as 
well as the holoenzyme, activates phosphodiesterase and myosin light chain kinase in the 
presence of calcium and confers calcium sensitivity to the holoenzyme is provided by the 
 subunit. 
Glycogen phosphorylase b (Pb) is the only known in vivo substrate for Phk, even 
though myelin basic protein, k-casein, and skeletal muscle troponin complex and 
troponin T are known to be phosphorylated by Phk in vitro (Pickett-Gies and walsh, 1986 
a). Recent studies by Boulatnikov et al., (2008) showed that glyceraldehyde3-phosphate 
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dehydrogenase (G-3DH), an intermediatory enzyme in glycolysis, is also phosphorylated 
by Phk, and its phosphorylation activity depends upon Ca
2+
and pH.  Interaction of G-
3DH with Phk provides evidence for the direct link between glycogenolysis and 
glycolysis (Boulatnikov et al., 2008).   
Regulation of Phk in relation to its function is a highly complex process. Phk 
activity is well regulated by the extracellular hormone epinephrine and also Ca
2+
. 
Epinephrine is known to activate glycogenolysis in skeletal muscle. The downstream 
targets in the epinephrine signaling pathway are protein kinase A, Phk, and Pb (Yeaman 
and Cohen, 1975). Epinephrine triggers the activation of Pb thus providing the energy for 
the cell to meet the requirements of muscle contraction. The holoenzyme itself is 
regulated by the autoinhibitor sequences present in the  and  subunits which bind to the 
catalytic site resulting in inhibition of the phosphotransferase activity. Phosphorylation of 
both the  and  subunits by cAMP dependent kinases regulates the phosphotransferase 
activity of Phk (Ramachandran et al., 1987).  Even though there is no evidence for 
autophosphorylation of Phk in vivo, in vitro studies showed that autophosphorylation of 
the regulatory subunits by Phk itself increases its specific activity (Hallenbeck and 
Walsh, 1983).  In vitro studies have revealed that the phosphotransferase activity of the 
Phk holoenzyme is highly dependent on pH changes, whereas the purified  complex is 
less dependent. With an increase in pH from 6.8 to 8.2, the activity also increases (Chan 
and Graves, 1982).  The exact mechanism of how increases in pH relieve the inhibition of 
the holoenzyme by the regulatory subunits is not known.   
 
     As previously discussed, Ca
+2 
is also known to be a major regulator of the 
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phosphotransferase activity of Phk. Calcium enhances the activity of the enzyme by 
directly binding to the  subunit.  Extrinsic calmodulin, ’ is also known to activate 
(Pickett-Gies and Walsh, 1986 b) the enzyme by binding to the  and  subunits (Picton 
et al., 1980).  Both extrinsic and intrinsic calmodulin molecules depend upon on Ca
2+
for 
Phk activation. Limited proteolysis of the  and  subunits by trypsin raises the enzyme 
activity at pH 6.8 (Cohen, 1973).  
 
 
B. Protein-protein interactions and the Yeast Two-Hybrid System 
Protein-protein interactions are a fundamental phenomenon for majority of 
cellular function. The majority of biological processes such as DNA replication, 
transcription, translation, and splicing depend on the interaction between specific proteins 
in the cell. Several enzymes including hemoglobin, the pyruvate dehydrogenase complex, 
Phk, and RNA polymerase all have multiple subunits. Interactions among the individual 
subunits are highly specific and are very important for the enzymatic functions and 
regulation. In addition to this, several transient protein-protein interactions also exist 
within the cells which regulate processes such as signal transduction, metabolic 
pathways, and cell cycle regulation. Transient protein-protein interactions are observed 
between protein modifying enzymes such as kinases, phosphatases, glycosylases, and 
their substrates. Interaction between proteins or among the subunits of enzymes has 
several effects within the cell. One such major effect of protein-protein interactions is 
dynamic changes in the kinetic properties of the enzymes. For example, in the 
nonactivated holoenzyme, quaternary interactions of the  and  subunits inhibit the 
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catalytic activity of the  subunit of Phk (Paudel and Carlson, 1987). 
Sequencing the human genome and assigning function to the newly identified 
gene products is one of the biggest challenges for biologists today.  One of the best ways 
to determine function of newly identified gene products is to study the protein with which 
it is interacting in the cell.  Therefore, understanding protein-protein interactions that 
occur within the cell is very crucial.  Several biochemical and genetic methods have been 
developed to study protein-protein interactions.  Commonly used biochemical techniques 
to study protein-protein interactions in vitro are co-immunoprecipitation, cross linking, 
and affinity blotting.  Genetic methods such as the yeast two-hybrid system and phage 
display are also widely used to study protein-protein interactions in vivo (for review see 
Phizicky and Fields, 1995). Extensive research on the eukaryotic transcription factor 
Gal4 was a breakthrough for the development of the yeast two-hybrid system. Gal genes 
are required for the growth of the yeast cells on galactose medium, and consist of the Gal 
1, 7, 2, 10 structural genes and the Gal 3, 4, 80 regulatory genes. Gal4 is an important 
transcriptional activator that regulates the transcription of the Gal 1, 7, 10 structural genes 
by binding to the upstream activator sequences (for review see Traven et al., 2006). The 
Gal4 transcriptional activator has a DNA binding domain and an activation domain; these 
two domains can be separated from each other physically and functionally. This was 
shown by fusing the -galactosidase encoding lacZ gene to the Gal4 DNA binding region 
followed by the detection of the gal4- -galactosidase fusion protein in yeast cells. The 
fusion protein was localized to the nucleus. Silver et al., (1984) also showed that only the 
74 N- terminal amino acids are required for sufficient nuclear localization of the gal4- -
galactosidase fusion protein.  The N-terminal 1-98 amino acid region of this DNA 
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binding (BD) domain alone will not activate the transcription (Keegan et al., 1986).  
 
 
 
 
 
Fig. 1.3 Schematic representation of the yeast two-hybrid system.  A. The coding 
sequence of bait protein (X) is cloned into BD containing vector which expresses BD-bait 
fusion protein B. Coding sequence of prey protein is cloned into an activation domain 
containing vector which express the AD-prey fusion protein C.  Interaction of protein X 
with protein Y results in the reconstitution of the transcription factor and expression of 
the reporter gene. (Promega protein interaction guide, Chapter 1, yeast two-hybrid 
system, pp 1-3). 
 
 
 
 
 
 
 
A 
B 
C 
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The functional activity of the separated DNA binding (BD) and activation domain 
(AD) of the Gal4 transcription factor was also later demonstrated by constructing the 
Gal80-AD fusion protein which was able to activate the transcription of downstream 
targets that are under the control of UASG by interacting with the Gal4 transcription 
factor.  Thus, the BD and AD do not need to be in the same polypeptide for them to 
function (Ma & Ptashne, 1988).  If the BD and AD are physically separated and they do 
not interact with each other, they will not activate transcription of the genes.  However, if 
the BD and AD are physically close to each other, they will activate transcription.  This 
was first shown by Fields and Song (1989).  In their work, the Gal4 BD and the Gal4 AD 
were fused to the well characterized interacting proteins SNF1 and SNF4, respectively, 
and then transferred into yeast cells. Interaction between these two proteins, SNF1 and 
SNF4, resulted in the BD and AD being physically close to each other. Positive 
transcriptional activation was measured by -galactosidase activity of the Gal1- -
galactosidase fusion protein (Fields and Song, 1989). 
The yeast two-hybrid system has advantages over classical biochemical 
techniques such as co-immuno precipitation, cross linking, and affinity blotting. One of 
the major advantages is that it uses yeast cells as host cells, which have greater 
resemblance to higher eukaryotes. Also, transient interactions that occur in the cell are 
relatively weak, and such weak interactions can be detected in the yeast two-hybrid 
system. By using the yeast two-hybrid system the strength of interaction between the 
interacting proteins can also be measured (Sobhanifar, 2003). By using this system, any 
protein of interest termed a “bait” protein, can be screened against library proteins fused 
to AD to identify new binding partners for the bait (Chien et al., 1991).  
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Even though the yeast two-hybrid system is extensively used to study protein-
protein interactions, it has some limitations. Posttranslational modification such as 
glycosylation occurs in the endoplasmic reticulum. As all the fusion proteins are targeted 
to the nucleus, interactions that depend upon post translational modifications cannot be 
detected in the yeast two-hybrid system.  Thus, it has limitations for the use in detecting 
associations with extracellular and membrane associated proteins (Allen et al., 1995). 
Also, fusion proteins which are used in the two-hybrid system may change the 
conformation of the bait or prey, resulting in alteration of the binding activity of the 
proteins (Sobhanifar, 2003). 
The first two-hybrid method developed was based on the Gal4 transcription factor 
(Fields and Song, 1989). In the Gal4 dependent yeast two-hybrid system, the yeast strain 
used for this study carried a deletion of the Gal4 and Gal80 genes, and grew more slowly 
than the wild-type strain. In order to avoid such problems, the LexA based method, also 
known as “interaction trap”, was developed (Golemis et al., 2008). LexA is a repressor 
protein (Ebina et al., 1983) that represses the transcription of the several SOS genes in 
E.coli.  Brent and Ptashne (1984) showed that the LexA protein expressed in yeast cells 
was passively transported into the nucleus and repressed the transcription of Gal1 
promoter derivatives containing at least two LexA operators.  
In the LexA-based system, nutritional markers used for selection are different 
from other two-hybrid systems. The bait plasmid contains the LexA DNA BD, and it is 
maintained in the cells by the presence of the HIS3 gene which confers histidine 
prototrophy to the cells. The prey plasmid contains the B42 AD, and cDNA is inserted 
into the prey plasmid so that it will express cDNA-B42 AD fusion proteins. The prey 
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plasmid is maintained by the presence of the TRP1 gene conferring the ability to grow in 
the absence of tryptophan.  The AD fusion protein produced in the cell is under the 
control of the GAL1 promoter, whose expression is induced by growing the cells in 
medium which contains galactose/raffinose. AD fusion protein levels are tightly 
regulated by this inducible promoter. This kind of regulation allows the cells to protect 
the normal cellular functions from the toxic fusion proteins. A low background 
LexAoperator-LEU reporter gene which is located on the chromosomal DNA is used to 
monitor the protein-protein interactions. It has six LexA operators upstream of the LEU2 
gene. The second reporter gene LexAoperator-LacZ is maintained on the URA3 (uracil 
prototrophy) based plasmid. This plasmid has eight LexA operators upstream of the LacZ 
gene (Bartel and Fields, 1997). This kind of dual selection method makes the yeast two-
hybrid system more reliable by reducing the number of false positives (Allen et al, 1995). 
The LexA repressor tagged bait fusion protein potentially reduces auto activation of the 
reporter genes (Allen et al., 1995). 
Protein-protein interactions are monitored in vivo by leucine prototrophy and 
LacZ expression. The second reporter gene monitors LacZ gene expression in the cells 
which makes the -galactosidase enzyme. Its activity can be measured by using different 
substrates. The most commonly used substrate is 5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside (X-gal). Beta-galactosidase converts the colorless substrate, X-Gal, 
into a blue color product. A more sensitive -galactosidase assay uses the substrates 
ONPG and 1, 2 dioxetane which allow for measurement of the strength of the interactions 
quantitatively (Gietz et al., 1997). 
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C. Rationale of the project 
Phk is a highly complex enzyme consisting of 16 protomers. Regulation of the 
phosphotransferase activity of Phk is a highly complex process. Extensive research has 
been carried out to understand the interaction of the protomers of the Phk and their role in 
the regulation of phosphotransferase activity. Understanding the spatial distribution of 
Phk is also very important.  Winchester et al., (2007) showed by using EST and Uni Gene 
databases that Phk is expressed in nearly 28-36 different tissues, and that the and  
subunits undergo extensive alternative transcriptional processing.  In addition, they also 
found that there is a weak polyadenylation signal in intron6 of the gene which encodes 
for the subunit, PHKG1. An intronic polyadenylation signal will allow for alternative 
processing of the mRNA corresponding to the  subunit. In silico translation of the 
alternatively processed mRNA resulted in a  subunit with 181 amino acids ( 181) 
followed by an additional 21 amino acids which are derived from the intronic region. 
These unique C terminal 21 amino acids are highly conserved among primates.   
Biochemical evidence also showed that 181 mRNA is expressed in the brain, heart, 
skeletal muscle, and tongue with brain having the higher levels (Winchester et al., 2007).  
The truncated form of the  subunit lacks residue E 182 which determines the specificity 
of the enzyme for the Phb substrate. Furthermore the prosite database revealed that the 
unique 21 amino acids at the C-terminus of 181 has a putative protein kinase C (PK-C) 
phosphorylation site. Surprisingly, despite being truncated, recombinantly expressed 181 
retains its kinase activity toward a peptide substrate, and this activity depends upon 
phosphorylation of 181 by PK-C (Unpublished data). In vivo substrates are currently not 
known for the 181 subunit. In this study we have used the LexA based yeast two-hybrid 
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system to identify potential binding partners for 181 in the brain. 
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MATERIALS AND METHODS 
 
A. Yeast and bacterial strains
The yeast strain used for the yeast two-hybrid screening was EGY 48 (MAT a, 
his3, trp1, ura3, 6ops-Leu2) (Clontech, Mountain View, CA). All plasmid manipulations 
were carried out in E. coli strain DH5. The brain cDNA library was amplified in the 
high efficiency transformation strain DH10B ( MegaX DH10B™ T1R Electrocomp™ 
Cells, Invitrogen).  All of the library plasmids were rescued in the E. coli strain KC-8 
(hsdR, leuB600, trpC9830, pyrF::Tn5, hisB463, lacΔX74, strA, galU,K). 
 
B. Two hybrid plasmids 
pLexA, pB42, pJK101, and p8op-LacZ plasmids were used for this study (Table 
1). All of the basic plasmids were obtained from Clontech (Clontech, Mountain View, 
CA). The pLexA basic vector (Fig. 2.1) was used for cloning the coding sequence of the 
bait protein. Other constructs cloned into the pLexA vector were p53, and the Drosophila 
bicoid protein coding sequence. The ADH1 promoter controls the expression of LexA 
fusion proteins. HIS3 is the marker used for selection in the yeast. The pB42 AD vector 
was used for cloning the cDNA library.  A human fetal brain cDNA library cloned into 
the pB42 vector (Fig. 2.2) was kindly provided by Dr. Erica Golemis of Fox Chase 
Cancer Center, Philadelphia, PA.  The GAL1 promoter controls the expression of the 
B42-cDNA cassette. The cassette also included a nuclear localization signal for targeting 
the B42-prey fusion proteins to the nucleus and a hemagglutinin epitope tag for 
assessment of the size of the encoded protein. This vector also has a TRP1 marker for 
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selection in the yeast cells. The p8op-LacZ plasmid (Fig. 2.3) is the most sensitive 
reporter plasmid used in the LexA based two-hybrid system. It has eight LexA operators 
followed by the LacZ reporter gene. It has a URA3 marker for selection in yeast cells. 
Other plasmids used in this study include, pJK101, pRFHM1, and pLexA-POS plasmids 
which were used for the repression assay. The pJK101 plasmid has an UASG followed by 
the LexA operator sequence followed by LacZ reporter gene. It has URA3 marker for 
selection in the yeast cells. pRFHM1 expresses LexA-bicoid fusion proteins used as a 
positive control in the repression assay.  pLexA-POS expresses a LexA-GAL4AD fusion 
protein, and was used as negative control in the repression assay. Both pRFHM1 and 
pLexA-POS have a HIS3 marker for selection in the yeast cells. Transcriptional 
repression of the LacZ gene by LexA- 181 was compared with the negative control 
LexA-bicoid protein. All of the plasmids used in this study have an ampicillin marker for 
selection in bacteria (Bartel & Fields, 1997). 
\ 
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Table 1: Plasmids used in this study 
 
 
 
 
Plasmid  Marker Characteristic features 
 
 
PLexA 
 
 
His3, Amp
R
 
Has a LexA BD followed by the polylinker under the 
control of ADH1 constitutive promoter. Used for cloning 
the coding sequence of the bait protein. 
                                                             
 
 
 PB42-
empty 
 
 
Trp1, Amp
R
 
Gal1 promoter expresses nuclear localization domain, 
transcriptional activation domain, HA epitope tag. 
Used for cloning  the cDNA library. 
 
 
p 8op-LacZ 
 
 
Ura3, Amp
R
 
Used as a sensitive reporter plasmid in the LexA based 
two-hybrid system. It has eight LexA operators followed by 
the lacZ reporter gene. 
 
pLexA-pos 
 
 
His3, Amp
R
 
Expresses LexA-Gal4p fusion protein. Expresses LexA-
Gal4AD fusion protein, used as negative control for 
repression assay. 
 
pRFHM1 
 
His3, Amp
R
 
Expresses LexA-bicoid fusion protein. Used as a positive 
control for repression assay. 
 
 
pJK101 
 
 
Ura3, Amp
R
 
Has a UASG followed by two LexA operators followed by 
lacz gene. Used in the repression assay for the detection of 
the nuclear localization of the LexA fusion proteins. 
pLexA- 181 His, Amp Expresses LexA- 181 fusion protein 
pB42-cDNA Trp, Amp Expresses B42-cDNA fusion proteins 
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Fig. 2.1 pLexA vector.  The human cDNA sequence encoding was cloned into 
multiple cloning site (MCS) of the pLexA vector to use as bait in yeast two-hybrid 
screening. It has a LexA DNA BD and a constitutive ADH1 promoter that regulate the 
expression of LexA fusion proteins. HIS3 is used as a marker for selection in yeast 
(Gyuris et al., 1993). The ampicillin resistance gene, Amp
r
 and the pBR origin allows 
selection and replication in E.coli. The 2  plasmid origin allows replication in yeast. 
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Fig. 2.2 pB42AD vector. The human fetal brain cDNA library was cloned into the MCS 
of the pB42 vector to use as prey in the yeast two hybrid screening. It has a B42 AD and 
the GAL1 inducible promoter regulates expression of cDNA-B42 fusion proteins. The 
transcriptional terminator is derived from ADH1. A hemagglutinin epitop tag (HA) and a 
nuclear localization signal are also present on the plasmid. TRP1 is used as a marker for 
selection in yeast (Gyuris et al., 1993). The ampicillin resistance gene, Amp
r
 and the pBR 
origin allows selection and replication in E.coli. The 2  plasmid origin allows replication 
in yeast. 
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Fig. 2.3 p8op-LacZ plasmid.  The LacZ gene is used as reporter of -galactosidase 
activity. The LacZ gene is under the control of 8 lexA operators and a minimal TATA 
region form the GAL1 promoter. URA3 is used as a marker for selection in yeast 
(Estojak., 1995). The ampicillin resistance gene, Amp
r
 and the pBR origin allows 
selection and replication in E.coli. The 2  plasmid origin allows replication in yeast. The 
ampicillin resistance gene, Amp
r
 and the pBR origin allows selection and replication in 
E.coli. The 2  plasmid origin allows replication in yeast. 
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C. Cloning of 181 into the pLexA vector 
Human cDNA corresponding to the sequence of 181 gene was synthesized by 
Genescript (Genescript, Piscataway, NJ)  and cloned into pUC57 with optimized codon 
usage in E. coli. pUC57- 181 was used as the template for PCR amplification of 181 
using the following primer pairs: gamma forward 
(ATCCGGAATTCATGACCCGGGACGA) and gamma reverse 
(ATCGCGGATCCCTATTCTGCAGATGG). Both primers contain restriction sites for 
EcoRI and BamH1, which allowed the amplicon to be digested with restriction enzymes 
EcoRI and BamHI (New England Biolabs) and ligated into precut pLexA with the same 
restriction sites. The PCR reaction was carried out in a Techne TC-512 thermocycler for 
25 cycles under the following conditions: initial denaturation at 94 
o
C
  
for 1min, 
denaturation at 94 
o
C for 1min, annealing at 60 
o
C for 2min, extension at 72 
o
C for 1min, 
final extension at 72 
o
C for 5min. The insert and vector were combined in a 10:1 volume 
ratio with T4 DNA ligase (Takara ligation kit) to carry out the ligation.  The ligation mix 
was incubated at 16 
o
C for 4 hrs. After incubation, the ligation mixture was directly 
transformed into DH5  chemically competent cells by heatshock at 42 
o
C. Positive 
clones were selected by plating the transformants on LB plates containing 100 g/ml of 
ampicillin. 
 
D. Yeast transformation 
 
EGY 48 cells containing the p8op-LacZ plasmid were made competent by 
growing 5 ml of overnight culture in synthetic media (SD) lacking uracil (SD-URA) 
medium (Clonetech, Mountain View, CA) followed by subculturing into 300 ml of the 
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same media. Subcultured cells were grown for 2-3 hours until mid log phase or an optical 
density (OD) 0.4-0.5nm. Cells were resuspended in 1.5 ml of 0.1 M lithium acetate 
(LiAc), 1M Tris-EDTA (TE) buffer and then shaken at 250 rpm for 30 min at 30 
o
C. 
These competent cells were then used for the transformation of the bait and library 
plasmids.  The transformation mix was prepared by combining 1 g of plasmid DNA, 10 
l of 10 mg/ml carrier salmon sperm DNA, 100 l of  yeast competent cells, and 600 l 
of 40% polyethylene glycol (PEG) solution (1X TE, 0.1M LiAc, 40% PEG). The 
transformation mix was incubated at 30 
o
C for 30 min at 250 rpm, followed by the 
addition of 70 l dimethyl sufoxide (DMSO) and heating at 42 
o
C for 15 min 
(Matchmaker LexA two-hybrid system and Matchmaker LexA libraries user manual, 
Clontech, Mountain View, CA). The cells were plated onto glucose based SD media 
lacking uracil, histidine, tryptophan (SD-U-H-T) and incubated at 30 
o
C for 2-3 days until 
colonies appeared. Glucose based synthetic media was used for normal maintenance of 
the plasmids in yeast cells. Another synthetically derived media used in this study was 
galactose/raffinose (SD gal/raf) based media which (Clontech, Mountain View, CA) was 
used to induce the expression of the library proteins. 
 
E. Isolation of LexA fusion proteins in the yeast cells 
Five ml of overnight culture of EGY-48 cells containing the bait (pLexA- 181) 
and reporter (p8op-LacZ) plasmids were grown in SD-U-H media, subcultured into fresh 
SD-U-H media, and grown until they reached mid log phase (OD~ 0.5-0.7). One and a 
half ml of culture was subjected to centrifugation for 3min at 13000xg and the resultant 
pellet was resuspended in 500 l of 50 mM Tris HCl/ 10 mM NaN3, pH 8.0. Following a 
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second centrifugation, the pellets were resuspended in 50 l of 2X SDS sample buffer           
(containing 2 ml glycerol, 5% SDS, 0.25 M Tris-HCl, 40 l of 5 mg/ml bromophenol 
blue, and 10% beta mercapto ethanol/10 ml). Samples were vortexed, boiled for 5 min, 
and frozen quickly in dry ice or liquid N2. After adding 50 l more 2X SDS buffer, cells 
were centrifuged at 13000xg for 5 min. The supernatant fraction was used for western 
blotting.  
 
F. Identification of LexA- 181 fusion protein expression in the EGY48 cells 
Whole cell proteins were extracted from the yeast cells containing bait and prey 
plasmids as mentioned above. After loading the samples onto a 4-20% polyacrylamide 
gel (Nu Sep gels), the gel was subjected to electrophoresis at 200 V for 1 hour, after 
which proteins were transferred to a PVDF membrane previously activated in 100% 
methanol for 15 min. Transfer of proteins at 100V was performed in transfer buffer (25 
mM Tris, 192 mM glycine, 10% methanol) for 1 hour.  Following the transfer, the 
membrane was blocked for 1 hour at room temperature with blocking solution (5% non 
fat dry milk powder, Tris buffer saline (TBS; 20 mM Tris base and 137mM sodium 
chloride, pH 7.6).  The blocked membrane was rinsed with TBS for 15 min and then 
incubated with rabbit polyclonal anti LexA (Millipore, Temecula, CA) antibody (1:20000 
dilution in 1% milk/TBS/0.1% tween 20) for 1-2 hours at room temperature. The 
membrane was washed three times with 1% milk/TBS/0.2% Tween-20 and then 
incubated with a goat anti-rabbit polyclonal alkaline phosphatase conjugated secondary 
antibody (1:10,000 dilution in 1% milk/TBS). Again the membrane was washed three 
times for 10 min each with 1% milk/TBS/0.2% Tween-20. After a quick rinse with TBS, 
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the membrane was incubated with 1ml of western blue stabilized substrate for alkaline 
phosphatase (Promega, Madison, WI) until color developed. The resulting image of the 
developed blot was scanned using a Hewlett-Packard Scanjet 4890.  
 
G. Human fetal brain cDNA library amplification 
The human fetal brain cDNA library cloned into pB42 was obtained from Dr. 
Erica Golemis (Fox Chase Cancer Center). This construct required amplification prior to 
library screening. Therefore, the vector was electroporated into high efficiency 
electrocompetent Mega X DH10B T1R E.coli cells. Sixty l of electrocompetent cells 
were combined with 0.5 l of pB42-cDNA library plasmid (60 ng/ l) into pre-chilled 0.1 
cm electroporation cuvettes (Fisher Scientific). The cells were electroporated at 2.0KV, 
200 ohm, 25 F by using the BIO-RAD gene pulser II apparatus. Immediately after 
electroporation, 1 ml of SOC media (2% bacto tryptone, 0.5% bacto yeast extract,  0.2% 
5M NaCl, 0.25% 1M KCl, 1% 1M MgCl2, 1% 1M MgSO4, 2% 1M glucose) was added 
to the electroporated cells. The cells were grown for 1hour. Eighteen l of cells 
representing three times the number of independent clones 3.5x10
6
, from this 
transformation were suspended in 51 ml of LB broth and then the entire mixture was 
plated on 150 mm LB plates containing 100 g/ml of ampicillin (300 l/plate). After 
incubation of the plates at 32 
o
C
  
for 18 hrs, cells were collected from plates in 4 ml of LB 
broth by scraping the cells off the plates. Plasmid was isolated from collected cells by 
using the Qiagen maxi prep plasmid isolation kit (Qiagen, Valencia, CA). 
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H. Library screening 
  EGY 48 cells containing bait (pLexA- 181) and reporter plasmid (p8op-LacZ) 
were made competent as described above.  pB42-cDNA library plasmids were 
transformed into the competent cells. Approximately 25 transformation reactions were 
carried out for library screening. For each transformation reaction, 10 l of pB42-cDNA 
library plasmid (126 ng/ l), 10 l of 10 mg/ml carrier DNA, 70 l of competent cells, 
and 600 l of a 40% PEG solution (1M TE, 0.1M LiAc, 40% PEG) were combined.  The 
transformation was carried out at as mentioned above. Cells were plated onto SD-U-H-T 
plates and then incubated at 30 
o
C for 2-3 days until colonies appeared. All cells were 
pooled into 5 ml of sterile water by gently scraping the colonies off each plate. Collected 
cells were resuspended in 60% glycerol solution and frozen in 1ml aliquots.  One ml of 
the glycerol stock was diluted in 500 ml of galactose/raffinose lacking uracil, histidine, 
and tryptophan (SD gal/raf -U-H-T) media and grown at 30 
o
C, 250 rpm for 12 hours to 
induce the library. Approximately 12 SD gal/raf-U-H-T-L plates were plated with 10
7
 
cells for library screening. Plates were incubated at 30 
o
C for 2-3 days until colonies 
appeared. 
 
I. Chloroform-agarose overlay assay for detection of potential interactions 
Colonies that appeared on SD gal/raf-U-H-T-L plates on day 3 of screening were 
streaked onto SD gal/raf-U-H-T plates. After incubating the plates for 2-3 days, each 
plate was overlaid with 10 ml of chloroform. The remaining chloroform was removed, 
and each plate was overlaid with 7-10 ml of X-gal agarose (1% low melting agarose, 0.1 
M NaHPO4 buffer pH 7.0, 0.25 mg/ml X-gal). Plates were incubated at 30 
o
C until color 
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developed. 
 
J. Rescue of library plasmid in the KC-8 bacteria 
Plasmid DNA was isolated from the putative positive EGY-48 yeast colonies that 
showed positive interactions during library screening by using the Zymoprep yeast 
plasmid miniprep kit II (Zymoresearch, Orange, CA).  Isolated plasmid DNA was 
electroporated into KC8 cells (Clonetech, Mountain View, CA) by using 1 mm gap 
cuvettes on BIO-RAD gene pulser II set to 1.8 KV, 10 uF, 600 ohm. After 
electroporation, cells were plated on M9-TRP selection media (7.5 mM (NH4)2 SO4, 33 
mM KH2PO4, 60 mM K2HPO4, 1.7 mM sodium citrate, 15 g agar, 1M MgSO4.7H2O, 
20ml 20% glucose, 0.74 g URA dropout mix (Clontech, Mountain View, CA ), 2 ml  1% 
thiamine HCl, and 50 g/ml ampicillin) to rescue the library plasmids. Plates were 
incubated for 2-3 days at 37 
o
C until colonies grew. Because of the selection pressure the 
cells effectively retained the library plasmid, but eliminated the bait as well as reporter 
plasmid. 
 
K. Redundancy determination 
To determine any redundancy among the isolated clones the screened library 
plasmids were digested with EcoRI and XhoI, or the frequent cutter HhaI (New England 
Biolabs, Baverly, MA). Digested plasmid DNA was loaded onto 0.7% agarose gel 
(containing 0.7% agarose, 2 l of ethidium bromide, 1X TBE buffer (0.089 M Tris, 
0.089M borate, & 0.002 M EDTA) and then electrophoresed at 100 V for 1hour. The 
restriction digestion pattern of inserts was compared with a 1kb DNA ladder (New 
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England Biolabs, Baverly, MA) or identified based on similar digestion patterns. Gel 
pictures were taken on an Alpha Innotech Fluorochem HD2 system. 
 
L. Sequencing and identification of positive clones 
 Plasmid DNA was isolated from the putative positive clones and used for 
sequencing. PCR reactions were carried out in a Techne TC-512 thermocycler by 
combining 200 ng of plasmid DNA template, Big Dye terminator ready mix v3.1 
(Applied Biosystems, Foster City, CA), 5 pM forward primer (CTC TGC TGA GTG 
GAG ATG C), and sterile water. Cycling was performed for 25 cycles as follows: 
denaturation at 96 
o
C for 30 sec, annealing at 50 
o
C for 15 sec, extension at 60 
o
C for 4 
min. Following amplification, the amplicon DNA was precipitated twice by using 75% 
isopropanol and dried in a speedvac. Each pellet was dissolved in 20 l formamide 
buffer.  Sanger’s dideoxy sequencing was performed and then samples were loaded on 
the sequencer (ABI PRISM 3130 Genetic Analyzer). Following the sequencing, the 
clones were identified by using the publicly available Gen Bank database such as 
BLASTN and BLASTP (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
 
M. Specificity testing 
Specificity of the 181 with its interacting proteins was confirmed by 
transforming the yeast cells containing the p8op-LacZ reporter plasmid with the 
following plasmids: pLexA-Phk encode the  subunit of Phk), pLexA-Phb N’ 
(encodes the N-terminus of the natural substrate of Phk), pLexA-Phb C’ (encodes the c-
terminal catalytic domain of the Phk substrate Pb) (Andreeva et al., 2002). Bait 
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transformed cells were also transformed with each putative positive clone and then grown 
on SD-U-H-T media at 30
o
C for 2-3 days. Positive transformants were streaked onto SD 
gal/raf –U-H-T plates and then assayed for -galactosidase activity as described above.  
 
N. Quantitative -galactosidase assay 
The Galactostar reporter assay system (Tropix) was used for quantitative 
measurement of -galactosidase activity in yeast cell lysates. The Galactostar system is 
very sensitive due to the use of the chemifluorescent substrate, 1, 2 dioxetane (Applied 
Biosystems Galacto star system protocol, pp 2-3).  Five ml of an overnight yeast culture 
grown in SD-U-H-T media was subcultured to induce library protein expression.  Cells 
were grown until they reached mid log phase (OD~0.5).  One and a half ml of the culture 
was centrifuged at 12000xg for 0.5 min and resuspended in 1X Z buffer (0.5 M sodium 
phosphate pH 7.1, 50 mM KCl, 5 mM MgSO4). Cells were again pelleted and then 
resuspended in 300 l of 1X Z buffer. Two quick freeze and thaw cycles were carried out 
for 100 l of cells in liquid nitrogen. Cells were pelleted by centrifugation at 12,000xg 
for 5 min at 4 
o
C.  Reaction buffer mix (300 l) was added to 20 l of the supernatant.  
The reaction buffer mix was prepared by 1:50 dilution of the substrate in reaction buffer 
diluent (100 mM sodium phosphate pH 7.5, 1 mM MgCl2, and 5% sapphire-II enhancer).  
The reaction mixture was incubated for 90 min and luminescence was measured by using 
a TD 20/20 Turner luminometer for 10 sec. Relative light units were recorded for each 
sample.  Data was represented as Modified Miller Units (MMU): the average of the 
relative light units normalized to the original yeast cell culture concentration (RLU/OD of 
the culture). 
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RESULTS 
 
A. Cloning and characterization of 181 bait 
The yeast two-hybrid assay was performed to identify 181 interacting proteins in 
vivo. Gamma 181, cloned into the pLexA vector, was used as bait, and a human fetal 
brain cDNA library cloned into the pB42 vector was used as prey in the screening 
process. To construct the pLexA-181 recombinant vector, PCR amplified, digested 181 
product was cloned into precut pLexA vector.  Results of the cloning indicated that out of 
12 isolated colonies, 11 contain the 181 insert as confirmed by restriction digestion (Fig. 
3.1).  The presence of 181 in the pLexA vector was further verified by sequencing the 
recombinant pLexA-181 plasmid.  
Additionally, before starting the actual screening process, the bait fusion protein 
(LexA-181) expression in EGY48 was verified by western blotting (Fig. 3.2). As seen in 
Fig. 3.2, when probed with an anti-LexA antibody, LexA-181 was efficiently expressed 
in the yeast, equal to or more than that of the positive control LexA-p53 protein. Another 
protein used in this study, LexA-Bicoid was also efficiently expressed in the yeast cells.  
In a two-hybrid study, all the proteins must be targeted to the nucleus since 
transcriptional activity is to be quantified as a report of protein interactions. Even though 
Brent and Ptasshne, (1984) showed that the LexA protein expressed in yeast is passively 
transported into the nucleus, verification of bait nuclear localization is necessary. The 
LexA-181 fusion protein nuclear localization was detected by a nuclear repression 
assay. 
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Fig 3.1. Identification of positive clones containing 181 in pLexA vector.  Plasmid 
DNA was isolated from the positive clones and then digested with EcoRI & BamHI. Size 
of the 181 was compared with the 1kb quick load DNA ladder (New England Biolabs). 
Gel lanes are indicated as 1. Marker, 2. PCR amplification of pUC57-γ181 (positive 
control), 3-14.  Restriction digestion of plasmids isolated from positive clones, 15.  
Restriction digestion of pLex-A vector (negative control). 
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Fig. 3.2. Identification of LexA fusion protein expression in yeast cells.  Whole yeast 
cell proteins extracts were probed for LexA fusion proteins using an anti-LexA antibody 
which recognizes the DNA binding regions of the LexA protein. Immunoblot was 
performed with the yeast cell lysates containing the following fusion proteins: Lane 1, 
Marker; Lane 2, LexA-p53; Lane 3 and 5, LexA-181; Lane 4, LexA-bicoid. Both the 
positive control p53 and the 181 bait are expressed in EGY48 yeast. 
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Fig.3.3. Repression assay for nuclear localization of LexA-181. Nuclear localization 
of 181 was identified by transcriptional repression of the LacZ gene. pLexA-181 
transformed yeast cells repress the transcription of the reporter gene identified as light 
blue color in the picture above. 
 
 
 
   
pJK101 + pLexA-181 pJK101+ pLexA-bicoid 
pJK101+ pLexA-POS 
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In this assay, LexA fusion proteins bound to the operator located in between the 
UAS and transcriptional start site inhibited the transcriptional activation of the 
downstream targets by the enhancers bound to the UAS.  pJK101 plasmid has an UASG 
followed by 8 LexA operators, followed by a lacZ  coding sequence. Yeast cells were 
transformed with pJK101, pLexA-181, pLexA-POS, or pLexA-bicoid in binary 
combinations for the repression assay and then transcriptional repression of the LacZ 
reporter gene was assayed. Nuclear localization of LexA-181 repressed the transcription 
of the reporter gene comparable to the positive control, bicoid, a nonspecific Drosophila 
transcription factor, indicating that LexA-181 efficiently localizes to the nucleus (Fig. 
3.3). As the yeast two-hybrid system is based upon the reconstitution of a functional 
transcription factor, checking for the autoactivation of the reporter genes (LEU2 and 
LacZ) by the bait protein alone is crucial for this study as it could lead to false positives.  
Autoactivation of the LexA-LEU2 gene by LexA-181 was tested by growing the yeast 
transformants containing LexA-181 alone or LexA-181 with pB42 AD in SD gal/raf-U-
H-T-L. Negligible growth was observed by the above transformants indicating that 
LexA-181 lacks the ability to auto activate the LexA-LEU2 reporter gene (Fig 3.4).     
 
B. Fetal brain cDNA library amplification 
A fetal brain cDNA library that represents 3.5x10
6 
independent clones was 
amplified prior to the screening process. During amplification the library was represented 
three times the number of 
 
independent clones. To get such a high number of independent 
clones the library was transformed into high efficiency electrocompetent cells DH10B 
and then plated onto LB-AMP plates. Transformation efficiency was calculated as 
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0.9x10
10 
CFU/g.  The amplified cDNA library concentration was 1262 ng/l and its 
purity (A260/280) was measured to be 1.88. 
 
C. Library screening 
To carry out the screening process, EGY48 yeast cells were transformed with the 
LexA-181 bait, the fetal brain cDNA library in pB42AD and the p8OP-LacZ reporter 
plasmid. Cells were plated on synthetic media lacking leucine for LEU2 selection. 
Putative positive interactions were identified by leucine protorophy and further confirmed 
by their phenotypic expression of -galactosidase activity on SD gal/raf –U-H-T+Xgal 
media.  Thirty seven putative positive interactions were observed based upon LEU2 
reporter gene expression. Of these 37 putative positive clones, only twenty showed 
positive interactions for the second reporter gene -galactosidase (Fig. 3.5).  The relative 
strength of interactions was determined based on the intensity of the blue color within a 
24 hour period. Scores were given to each colony with (++++) representing the strongest 
interactors and (+) being the weakest interactors (Table 2). 
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             SD-U-H + p8opLacZ                          SD-U-H-T                                    
LexA-181                     LexA-p53            LexA-181+B42 empty LexA-p53+B42-T ag 
                         
 
 
    SD gal/raf –U-H-L+ p8opLacZ                                    SD gal/raf–U-H-T-L                   
LexA-181                        LexA-p53          LexA-181+B42 empty LexA-p53+B42-T ag 
                          
 
Fig. 3.4. Testing bait 181 for transcriptional activation of reporter gene LEU2. 
Transcriptional activation of the reporter gene LEU2 was identified by growing either the 
LexA-181 or LexA-181+B42AD transformed EGY48 cells on synthetic growth media 
(SD-U-H-T) followed by transferring the cells to induction media (SD gal/raf –U-H-T-L) 
for expression of library proteins. p53 and pB42-Tag vectors were used as control 
plasmids. p8op-lacZ is the reporter plasmid. 
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Fig. 3.5. Putative positive interactors of 181. A total of 37 colonies showed positive 
interactions for leucine prototrophy. Interactions were further confirmed by the 
expression of the second reporter gene -galactosidase. Of those 37 colonies, 20 of them 
(labeled with numbers) were able to metabolize X-gal in the chloroform agarose overlay 
assay, as shown above.  
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S. No Putative positive clones that are showing 
positive interactions 
Strength of interaction 
1 25 ++++ 
2 27, 29, 30, 31, 32, 33, 35, 36, 37, 38 ++ 
3 1, 3, 4, 5, 6, 9, 10, 14, 15, 18, 19, 20, 23 + 
 
Table 2. Phenotypic expression of -galactosidase by the identified putative positive 
clones.  Putative positive colonies that showed leucine prototrophy were grown in the SD 
gal/raf-U-H-T selection media and phenotypic expression of the -galactosidase activity 
of the individual colony was observed after 24 hours. Clone numbers and the strength of 
their interactions, (++++) being the strongest, and (+) being the weakest interaction are 
listed in the table. 
 
 
In order to isolate the putative library plasmids from the yeast cells, positive 
clones were grown on SD-TRP selection media for two generations to eliminate the bait 
and reporter plasmids.  Subsequently, plasmid DNA was isolated from yeast by using a 
Zymoprep plasmid isolation kit and then retransformed into the E. coli strain KC8 
bacteria by electroporation. Transformants were allowed to grow on M9-TRP selection 
media. Following plasmid isolation from the KC8 bacteria, each library clone’s insert 
size was determined by the restriction analysis of the plasmids with EcoRI and XhoI. 
Based upon comparison to a 1kb DNA ladder, insert sizes ranged from 100-750 base 
pairs (Fig. 3.6).  Redundancy among the clones was also analyzed by digesting the 
screened library plasmids with the frequent cutter HhaI. Seven nonredundant clones were 
identified based on the restriction digestion pattern (Fig. 3.7).  The unique nonredundant 
clones were identified as clone 1, 5, 6, 9, 14, 25, and 35. All unique clones were 
sequenced and then identified by comparision to known sequences in the Gen Bank 
database by using the BLASTN search engine (Table 3). Of these 7 nonredundant clones, 
3 of them were translatable: 1, 5 and 25. Clones 1 and 5 correspond to the ribosomal 
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proteins L9, and L23, and 25 corresponds to the nuclear antigen 14 (NA14).  The clone 
showing the strongest interaction by -galactosidase screening showed maximum 
sequence homology to NA14. Three of the redundant clones 9. 19 and 36 show no 
sequence homology with any known transcripts or proteins. Column 1 in Table 3 
indicates the strength of interactions of these proteins with 181.  Since the 
truncatedsubunit of Phk has kinase activity, we hypothesize that it may phosphorylate 
the binding partners of 181 identified in this screen, such as ribosomal proteins, and 
NA14. Therefore, by using the PhosK program for predicting high potential 
phosphorylation sites in proteins (Bloom and Gammeltoft, 1999), we identified high 
potential serine/threonine  phosphorylation sites in the putative 181 binding partners. 
RPL9, RPL23 and NA14 all contain anywhere from 2 to 5 high potential phosphorylation 
sites for serine/threonine kinases (Fig. 3.8). 
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Fig. 3.6. cDNA library insert size determination by restriction digestion. 20 putative 
positive clones (Lanes 2-14) were digested with the restriction enzymes EcoRI and XhoI. 
cDNA library insert sizes ranged from 100- 750 bp as observed from the 0.7% agarose 
gel. Lane 1, NEB 1Kb DNA ladder; Lane 15, negative control pB42 vector. 
 
 
Fig. 3.7. Identification of redundant clones. Redundancy among the clones was 
identified by digesting the screened library plasmids (Lanes 2-17) with the frequent cutter 
HhaI. A total of seven unique clones was identified based on restriction digestion pattern 
as observed in 1% agarose gel. Lane 1, NEB 1Kb DNA ladder; Lane 15, control vector 
pB42. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
250 
500 
750 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
250 
500 
750 
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Table 3 Identification of isolated clones. Plasmids isolated from the putative positive 
clones were sequenced and then a BLASTN analysis was performed. The majority of the 
clones showed maximum sequence homology to ribosomal proteins.  
 
 
Strength of 
Interactions 
 
Library plasmid 
                         
                         Transcripts 
 
 
         + 
 
 
1/1, 5/10 
Homo sapiens ribosomal protein L23  
 
(RPL23) 
 
 
 
++, +, ++, 
++, ++ 
 
2/5, 7/18, 13/31, 
15/33, 19/37 
 
 
Homo sapiens ribosomal protein L9 (RPL9), 
transcript variant 1  
 
 
        +,++ 
 
6/14, 14/32 
 
Homo sapiens mitochondrial ribosomal protein 
L12 (MRPL12) 
 
 
           + 
 
3/6 
 
Homo sapiens peroxisome proliferator-activated 
receptor alpha 
 
       
        ++ 
 
17/35, 20/38 
 
Homo sapiens T-box 3 (TBX3), transcript 
variant 2 
 
        
      ++++ 
 
9/25 
 
Homo sapiens Sjogren syndrome nuclear 
autoantigen 1 (SSNA1)-aka NA14 
 
 
   +, +, ++ 
 
4/9, 8/19, 18/36 
 
No significant similarity found 
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D. Quantification of LexA-181 interactions with the RPL9, RPL23, NA14 
The relative strength of the interaction between 181 and each ribosomal protein 
and NA14 was measured quantitatively by using 1, 2 dioxetane, a sensitive 
chemifluorescent substrate for -galactosidase. To carry out the quantitative assay, prey 
plasmids containing ribosomal proteins or NA14 coding sequences were retransformed 
into yeast cells expressing pLexA-181 bait plasmid. When the 181 was assayed against 
the ribosomal proteins, -galactosidase activity measured to be 12.0 and 8.8 MMU for 
RPL23 and RPL 9, respectively. NA14, the strongest interactor with 181 in the overlay 
assay, had -galactosidase activity measuring 10.4 MMU. Interestingly, results obtained 
in the quantitative assay do not correlate with the overlay assay results. All activities 
measured are not significantly different when compared with the empty vector control, 
10.1 MMU (Fig.3.9).  For further verification, the overlay assay was performed again 
with the retransformed cells. As expected, NA14 again showed very strong interactions 
with 181. Whereas the ribosomal proteins interact relatively weakly (Fig. 3.10).   
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Fig. 3.8 Identification of high serine/threonine  phosphorylation sites High potential 
serine-threonine phosphorylation sites were observed in the 181 interacting proteins 
RPL23 (1), RPL9 (2), NA14 (3). 
 
 
 
3 
2 
1 
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The discrepancy in the data may be due to variability in cell lysis. Yeast cell walls 
are very tough.  Permeabilization of the cell wall and extraction of the whole -
galactosidase enzyme expressed in the cells is very important in the chemiflurorescent 
reporter assay system. Chloroform was used for permeabilization of the cell walls in the 
overlay assay, whereas Z buffer (containing sodium phosphate and magnesium sulphate) 
was used in the chemiflurorescent reporter assay. To eliminate the possibility that the 
association of 181 with RPL9, RPL23, and NA14 was due to nonspecific interactions, 
each protein was tested in binary combinations with three other proteins in the LexA 
vector: Pb N’, the N-terminal regulatory domain of Pb; Pb C’, the C-terminal catalytic 
domain of Pb; and Phk   Results from this specificity test (Fig. 3.11) revealed that Phk 
interacts with RPL23, Pb N’ interacts with all three 181 interactors, and Pb C’ 
interacts with RPl23 alone.                     
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Fig. 3.9. Relative interaction affinities of RPL9, RPL 23, NA14 with 181.  Gamma 
181 was assayed with RPL9, RPL23, and NA14. Empty pLexA and pB42 vectors were 
used as negative controls. Results are expressed as the mean ± S.E.M. of three separate 
experiments each carried out in duplicate. 
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Fig. 3.10. Repeat overlay assay.   For reconfirmation of the strength of the interactions, 
yeast cells containing pLexA-181 plasmid were transformed with NA14 (1), RPL23 (2), 
RPL9 (3), and B42 (4). As shown in the picture, NA14 interacts strongly (1) in the 
overlay assay. pB42 AD transformed cells (4) do not interact with the 181 protein. 
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Fig. 3.11. Specificity testing Specificity of the 181 interactors with the Phk , Pb N’, 
Pb C, were identified by chloroform overlay assay. As shown above, Pb N’ interacts 
nonspecifically with all three proteins tested, whereas Pb C’ interacts with RPL23, and 
Phk  interacts with RPL9.  
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DISCUSSION 
 
By using a yeast two-hybrid system we have identified novel interacting proteins 
of the PHKG1 variant 181 as NA14, RPL9, and RPL23. NA14 is an autoantigen which 
is recognized by autoimmune serum from patients with Sjogren’s syndrome. 
Autoantibodies raised against nuclear, cytoplasmic and cell surface components are the 
most common characteristic features in autoimmune diseases such as systemic lupus, 
rheumatoid arthritis, and Sjogrens syndrome.  Structurally, NA14 consists of a coiled-coil 
domain and a basic C-terminal domain. Coiled-coil domains are characteristic of other 
nuclear autoantigens. Immunofluorescence studies revealed that NA14 is localized to the 
nucleus (Ramos-Morales et al., 1998). Even though NA14 lacks a nuclear localization 
signal, it is transported into the nucleus either by interacting with another nuclear protein 
or by passive diffusion because of its small size. NA14 is expressed in almost all tissues, 
with its expression in testis being very high (Ramos-Morales et al., 1998).  
The centrosomal deflagellation inducible protein (DIP13) of Chlamydomonas 
reinhardtii shows 60% sequence homology to NA14. DIP13 is localized to the basal 
bodies and cytoplasmic microtubules. Because of the sequence similarity of NA14 with 
DIP13, cellular localization of the NA14 was reexamined using anti-DIP13 antibodies as 
well as anti-NA14 antibodies, as both of them recognize NA14. Interestingly, 
immunological studies showed that NA14 localizes to centrosomes and not to the nucleus 
as previously reported (Pfannenschmid et al., 2002). 
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The role of the NA14 in the centrosomes is currently unknown. Co-
immunoprecipitation and yeast two-hybrid studies showed that NA14 interacts with 
spastin, a centrosomal protein (Errico et al., 2004). Spastin triggers the depolymerization 
of the central spindle microtubules by its microtubule severing activity. NA14 acts as an 
adaptor protein and helps in targeting the spastin to the centrosomes, thus playing an 
important role in microtubule dynamics (Errico et al., 2004). Posttranslational 
modifications of NA14 are currently not known. However, PROSITE database analysis 
revealed that it has consensus motifs for N-glycosylation, a casein kinase II 
phosphorylation site, and a PKC phosphorylation site (Ramos-Morales et al., 1998).  
Another major category of binding partners identified for 181 were ribosomal 
proteins. All ribosomes, irrespective of their origin, contain RNA and proteins. 
Prokaryotes have 70S type ribosomes whereas eukaryotes have 80S ribosomes. The RNA 
to protein weight ratio is 2:1 and 1:1 for prokaryotes and eukaryotes, respectively (Spirin, 
1999). Both large and small subunits of the ribosomes have several different protein 
components. Proteins in large and small subunits are indicated by L and S respectively 
followed by a number. Ribosomal proteins are integral components of the ribosomes. 
Collectively, all of the proteins play a crucial role in the translation process. Assigning 
function to ribosomal proteins is very difficult, but based on the position of these proteins 
in the subunit, one can infer function in general terms.  The ribosomal protein L9 is 
critical for ribosome function because anti-RPL9 antibodies significantly reduce protein 
synthesis (Nag et al., 1991).  The crystal structure of the ribosomal protein L9 has been 
well characterized by X-ray diffraction studies. It has bilobal structure with two 
ribosomal binding domains that are connected to each other by long  helical coils. Both 
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domains have conserved aromatic and basic amino acids that likely play an important 
role in binding to the ribosomes. RPL9 helps in ribosomal assembly and maintains the 
catalytically active conformation of the RNA molecule (Hoffman et al., 1994, 1996).   
  In addition to the traditional cell role of ribosomal proteins, a regulatory role for 
RPL23 has been identified with respect to the transcription factor p53.  p53 is a tumor 
suppressor protein that primarily mediates transcription of several proteins involved in 
cell growth arrest, apoptosis, and inhibition of angiogenesis, thus protecting the cells 
from malignancy (Sharpless and DePinho, 2002; Vogelstein et al., 2000).  Because of its 
tumor suppressor function, tight regulation of p53  is very important for normal growth 
and development of cells. One of the major players that regulates p53 activity in cells is 
MDM2, a protein which blocks transcriptional activity of p53 (Momand et al., 1992).  
MDM2 is a ubiquitin ligase and its interacation with p53 initiates the ubiquitination of 
p53 leading to proteosomal degradation (Kubbutat et al., 1997, Honda et al., 1997).  
Proper ribosomal assembly and function are very important for normal functioning of 
cells. Stress on ribosomal biogenesis also regulates the p53-MDM2 feedback loop. In 
response to ribosomal stress, RPL23 activates p53 by inhibiting its interaction with 
MDM2 (Dai et al., 2004).  
Posttranslational modification of ribosomal proteins is known to occur in 
reticulocytes and liver cells. In vivo phosphorylation of ribosomal proteins in rabbit 
reticulocytes has been shown by Kabat (1970).  Traugh et al., (1993) successfully isolated 
three different protein kinases from rabbit reticulocytes that phosphorylate proteins of the 
40S as well as 60S subunits.  Two of the kinases have similar substrate specificity; one is 
dependent on cAMP for phosphotransferase activity, whereas the other is independent of 
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cAMP (Traugh et al., 1973). Rabbit liver ribosomal proteins are also phosphorylated by 
cAMP dependent kinases such as protein kinase I (PKI) and protein kinase II (PKII). PKI 
is more efficient at phosphorylating the ribosomal proteins than PKII (Eil & Wool, 1973). 
In this study, we have identified high potential serine/threonine  phosphorylation sites in 
the 181 interacting proteins RPL9, 23, and NA14 by using the publicly available 
NetPhosK bioinformatic tool. Biological significance of the posttranslational 
modifications of ribosomal proteins as well as NA14 is currently unknown. 
It should be noted that reports from yeast two-hybrid studies, have shown that 
ribosomal proteins are quite often identified as false positives. We also observed some 
weak interactions among ribosomal proteins and 181. Since the identified interactions 
were relatively weak, and because RPL9 and RPL23 both interact with many other 
proteins nonspecifically, it is likely that they are false interactions. 
When 181 was used to screen a human fetal brain cDNA library, we identified 3 
major interacting proteins. Those 3 proteins were identified as ribosomal proteins L9, 
L23 and NA14.  The ribosomal proteins, as well as NA14, are unique proteins due to the 
fact they do not have any known conserved domains. Previous work from our lab has 
shown that an expressed recombinant 181 subunit is catalytically active in vitro against a 
synthetic substrate called the S peptide, and its activity depends on phosphorylation by 
protein kinase C (PK-C) (unpublished data).  Based upon our results by NetPhoK 
predictions, all 3 identified 181 interactors have potential serine/threonine 
phosphorylation sites that could be phosphorylated by 181.  Comparision of these sites 
with the phosphorylation sites of S peptide (SDQEKRKQIS
* 
VRGL) revealed that the 
181 interacting proteins and the S peptide phosphorylatable seryl residue is surrounded 
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by conserved basic amino acid residues (Fig.4.1).  The consensus sequence deduced from 
the ribosomal proteins and NA14 has similar characteristic features as the in vitro 
substrate S peptide.   
           
Fig. 4.1. Sequence alignment of high potential phosphorylations sites. High potential 
phosphorylation sites of 181 interacting proteins were compared with the artificial 
substrate S peptide. Basic conserved amino acid residues surrounding the convertible 
serine residue are marked in yellow boxes.  
 
Furthermore, similarity in the substrate recognition site was observed in the case 
of the Phk holoenzyme. Phk recognizes the consensus sequence K/R-X-X-S*-V/I-R 
deduced from its natural substrates such as Pb, glycogen synthase and the  subunit of 
Phk itself (Pearson & Graves, 1991). Basic amino acid residues surrounding the serine 
residue are very important in substrate recognition. Arginine at P+2 activates Phk (Pickett-
Gies and Walsh, 1986 b).  Since the amino acids surrounding the serine residue in all 
three identified proteins show a similar pattern as the in vitro substrate S peptide, it is 
possible these ribosomal proteins and the NA14 are phopshorylated by 181 in vivo.  
Comparison of the full length and truncated gamma subunit’s structures, as 
predicted by using the I-TASSER folding program (Zhang, 2008, unpublished data), 
R  K  Q   I   S   V  R  G  L 
R  K   I   A  S   N  R  E  F 
R  K  M  R  S  V   R  A  H 
P  L  P   N  S   A   R  G E 
* S peptide 
NA14 
RPL9 
RPL23 
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reveal that 181 lacks much of the kinase helical domain. As a result, we anticipated that 
from this study we would potentially identify some binding partners that might 
compensate for the loss of the helical domain and help in orienting substrates to the 
catalytic site of 181.  Additionally, since the unique C terminal 21 amino acids of 181 
contains the phosphorylation site for PK-C, we also expected to identify PK-C as an 
associated protein in our screen. Contrary to these predictions, we did not identify PK-C 
nor other proteins which may serve as adaptor or subunits in a larger complex.  
Alternatively, the three proteins that were identified appear to be potential substrates for 
the enzyme, although again, it is probable that the ribosomal proteins are false positives. 
Further research is needed to confirm phosphorylation of NA14 by 181. If  181 does 
not phosphorylate NA14, then we need to think about the physiological importance of 
this interaction in the brain. Previous reports say that NA14 acts as an adapter protein that 
helps in the localization of spastin to centrosomes. It is possible that interactions between 
181 and NA14 might cause conformational changes in the NA14 resulting in the 
exposure of known hydrophobic domains that play an important role in its interaction 
with spastin.  
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